Search results
Results From The WOW.Com Content Network
Location. Tampa, Florida. , USA. 27.7692739 -82.6412105. Website. moffitt.org. Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus. [2]
Dana-Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Receiving the NCI-designation places cancer centers among the top 4 percent of the approximately 1,500 cancer centers in the United States. The standards for Comprehensive Cancer Centers are the most restrictive of the types. These facilities must demonstrate expertise in each of three areas: laboratory, clinical, and behavioral and population ...
Frank Shane, a certified trauma responder, and Nikie, a K-9 disaster relief therapy dog, worked at Ground Zero for nine months after 9/11. HEROISM, BRAVERY DISPLAYED ON 9/11 BY PLANE PASSENGERS ...
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer.The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy ...
Cleveland Clinic Akron General, formerly known as Akron General Medical Center, and commonly known as Akron Gen, is a nationally ranked, 511-bed non-profit, teaching hospital located in Akron, Ohio. [82] In August 2015, the Akron General Health System joined the Cleveland Clinic Health System.
Yale University. Doctoral advisor. Frederick R. Maxfield. Peter Marks is an American hematologist oncologist serving as the director of the Center for Biologics Evaluation and Research within the Food and Drug Administration. He was appointed to the position in 2016 after previously serving as deputy director.
For premium support please call: 800-290-4726 more ways to reach us